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EDITORIAL
Nephropathy in the context of HIV infection
Renal complications are well recognized to have a sub-
stantive impact on the course and prognosis of patients
with HIV infection [1]. As summarized in Table 1, many
of the renal manifestations represent complications of
concurrent infections in a severely immunocompromised
host, or side effects of the plethora of treatments re-
quired to manage patients with HIV infection. Defini-
tion of the precise roles of the HIV virion and its gene
products in instigating pathology within the nephron has
been difficult, and most of the proposed pathogenetic
mechanisms remain controversial. Attempts to define
the pathogenesis HIV-driven renal disease, including in
vivo studies of immunodeficiency viruses affecting other
primate species, expression of HIV gene products in
transgenic animal models, and in vitro studies of HIV
infection in various cell components of the nephron
have not produced a consensus about HIV-driven disease
mechanisms.
The history of attempts to define various forms of
nephropathy in patients with HIV infection has also pro-
duced controversy. Just over 20 years ago, seminal re-
ports of nephropathy in AIDS patients from New York
[2] and Miami [3] described a form of focal segmental
glomerulosclerosis (FSGS), which later became known
as HIV-associated nephropathy (HIVAN). Interestingly,
early observations of AIDS patients studied here at the
National Institutes of Health in Bethesda, as well as in
San Francisco [4], Paris [5], London [6], and Bologna
[7], suggested that FSGS was infrequent, either clini-
cally or at autopsy. These studies indicated that other
nephropathies were more common, particularly throm-
botic microangiopathy and immune complex glomeru-
lonephritis (GN). Further analysis of the prevalence of
nephropathy among various cohorts of HIV patients sug-
gested that the type of glomerular disease segregated
primarily along racial lines [8]. Until the present, most
nephrologists have operated under the belief that black
race was the dominant factor determining susceptibility
to HIVAN (as for FSGS in general), and that the pre-
dominant nephropathies in other racial groups of pa-
tients with HIV were those mediated by immune complex
deposits [9].
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Data provided in the study by Haas et al, reported
elsewhere in this issue of Kidney International [10], will
undoubtedly modify our perspective on the differential
diagnosis of nephropathy, particularly among black pa-
tients with HIV. The Hopkins group reports a recent se-
ries of 77 renal biopsies taken from HIV patients. HIVAN
was diagnosed in 43% of black patients, while no cases of
HIVAN were diagnosed in white or Asian patients. Out
of 14 cases of lupus-like GN, 13 patients were African
American. The pathology subclasses roughly paralleled
that of ordinary lupus nephritis: 6 focal proliferative, 7 dif-
fuse proliferative, and 1 membranous nephropathy. The
presence of concurrent chronic hepatitis C did not track
with the deposition of immune complexes. The progno-
sis of the HIV-associated lupus-like nephropathy was ex-
tremely poor, with 10 of 14 patients progressing to end-
stage renal failure within one year of biopsy, paralleling
that of HIVAN (which, interestingly, was judged to be
present concurrently in 3 cases).
This study does not present findings of new forms of
pathology in patients with HIV. As noted above, im-
mune complex GN and lupus-like disease has been well
described. However, the findings of the present study
should serve to modify the prebiopsy estimate of the
likelihood of finding a particular class of renal pathol-
ogy in HIV patients with clinical evidence of glomerular
disease. White and Asian patients with HIV are likely
to have immune complex forms of glomerulonephritis
with a low likelihood of HIVAN or other forms of FSGS.
The key point that may affect current practice is to rec-
ognize that immune complex nephropathy (lupus-like
and other GN) is only modestly less likely than HIVAN
to account for glomerular disease among black patients
with HIV infection. The specific biopsy diagnosis will in-
crease in importance if it can be shown that selection
and outcome of treatment are different among the var-
ious forms of nephropathy seen in patients with HIV
infections.
Despite the foregoing modifications to our approach
to patients in clinical practice, the pathogenesis of the
nephropathies emerging in the context of HIV disease
remains very poorly understood [11]. The same applies
to understanding of host factors that may affect sus-
ceptibility to or modify the expression of HIV-based
pathogenetic processes. Factors affecting prognosis and
response to treatment need further refinement [12].
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Table 1. Range of nephropathies occurring in HIV patients
• HIV-associated nephropathy (collapsing variant of focal segmental
glomerulosclerosis, FSGS)
• Mesangial glomerulonephritis (GN) with immune deposits,
including IgA and Henoch-Schonlein purpura (HSP)
nephropathies
• Lupus-like GN
• Minimal change disease
• Membranous nephropathy
• Membranoproliferative GN, type 1
• Paraprotein nephropathies: light chain/amyloid/fibrillar
• Nephropathy of thrombotic thrombocytopenic purpura (TTP) or
hemolytic uremic syndrome (HUS)
• Nephropathies associated with concurrent chronic infections (e.g.,
hepatitis B, C)
• Acute tubular necrosis
• Allergic interstitial nephritis
• Crystal-induced nephropathy (certain protease inhibitors)
• Renal failure and Fanconi syndrome (certain reverse transcriptase
inhibitors)
• Kaposi sarcoma, infiltrative
• Lymphoma, infiltrative
Acquiring satisfactory answers to these questions will un-
doubtedly depend on interdisciplinary approaches, using
the tools of epidemiology, genetics, virology, molecular
and cell biology, and immunology, among others [13].
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